MARPAI ANNOUNCES GENERAL UPDATES FOR Q4
Marpai has secured a number of significant new accounts for 2025 TAMPA, Fla., Nov. 26, 2024 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX:MRAI), a technology platform company, operates…
Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today reported business updates and financial…
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
–Completed End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA); on track to initiate Phase 3 clinical program for MM120 orally disintegrating tablet (ODT) in Generalized Anxiety…